The principal aim of this pilot study was to determine whether circulating surfactant protein D (SPD) or Clara Cell protein-16 (CC16) levels are associated with lung function or health status in patients with severe COPD. This evidence concerns the gene SCGB1A1 and chronic obstructive pulmonary disease.